DAHANCA

Results: 3



#Item
1HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Mircera safely and effectively. See full prescribing information for Mircera. Mircera (methoxy polyethylene glyco

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Mircera safely and effectively. See full prescribing information for Mircera. Mircera (methoxy polyethylene glyco

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-10-08 13:53:43
2Aranesp® (darbepoetin alfa) For Injection WARNINGS: INCREASED MORTALITY, SERIOUS CARDIOVASCULAR EVENTS, THROMBOEMBOLIC EVENTS, STROKE and INCREASED RISK OF TUMOR PROGRESSION OR

Aranesp® (darbepoetin alfa) For Injection WARNINGS: INCREASED MORTALITY, SERIOUS CARDIOVASCULAR EVENTS, THROMBOEMBOLIC EVENTS, STROKE and INCREASED RISK OF TUMOR PROGRESSION OR

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2010-02-16 10:47:35
3Aranesp (darbepoetin alfa) Label

Aranesp (darbepoetin alfa) Label

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:49:43